Trials24 to Showcase Online Patient Recruitment Solutions at BIO International Convention 2024 in the U.S.

Trials24 will engage with fellow exhibitors and attendees, sharing insights and exploring collaborations to speed up clinical trials by fast-tracking patient recruitment. The company is particularly looking forward to discussions on several key topics, including:

• Projecting patient recruitment costs: With Trials24’s Patient-Reported Feasibility Studies, we build a recruitment cost model that projects patient enrollment costs by measuring the patient population’s eligibility rate specifically to the study protocol.
• Supporting Global Patient Recruitment: Showing with our case studies from common chronic illnesses to rare diseases how we accelerate patient recruitment by tapping into a patient pool study sites can’t reach.

Dr. Tobias Kruse, CEO of Trials24, says: “Connecting with leaders and innovators in biotechnology and clinical research to understand their patient recruitment challenges is the highlight of the BIO International Convention. We look forward to sharing with sponsors and CROs how we can help them accelerate patient recruitment with our approach. Our goal is to seamlessly facilitate the connection between patients and clinical trials, minimizing the workload for sites through rigorous pre-qualification of candidates and emphasizing enhancing diversity within trials. I personally value the opportunity to engage with industry key leaders to share and learn how to improve clinical trials patient recruitment together.”

Trials24 invites all attendees to join them at booth #4315-19 in the German Pavilion and to book a meeting via Partnering Platform or by email at info@trials24.com.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the entire ecosystem of biotech with over 20,000 industry leaders from across the globe. This event is held by the Biotechnology Innovation Organization (BIO), the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.

About Trials24

Trials24 accelerates patient recruitment for clinical trials globally, helping CROs and biopharmaceutical companies find patients their sites can’t reach. Based in Munich, Germany, Trials24’s approach centers around Online Patient Recruitment and Patient-Reported Feasibility Studies to ensure the predictability of their campaign’s successes, timelines, and costs. Thanks to a triple-prequalification process for patients before referral, each patient is carefully screened for eligibility, and sites enroll 20 to 40% of Trials24’s referred patients. Trials24 consistently delivers 20-65% of all randomized patients in clinical trials and often shortens the study recruitment period by six months or more. Explore further: trials24.com.

Trials24 Media Contact:

Trials24 GmbH

E: info@trials24.com

T: +49 89 21537 4990